DARE
Dare Bioscience, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.72
+1.11%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 6.13x
- P/S forward
- 2.31x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -24.94x
- Price / sales
- 10.23x
- Price / cash flow
- -1.24x
Enterprise value
- Enterprise value
- $8.1M
- EV / sales
- 5.94x
- EV / EBITDA
- -0.88x
- EV / EBIT
- -0.73x
- Market cap
- $14.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026